CytoSorbents Corp. (CTSO)
5.80
-0.26
(-4.29%)
USD |
NASDAQ |
Sep 16, 16:00
5.80
0.00 (0.00%)
After-Hours: 20:00
CytoSorbents Enterprise Value : 44.61M for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 44.61M |
| September 14, 2026 | 44.64M |
| September 11, 2026 | 45.71M |
| September 10, 2026 | 45.59M |
| September 09, 2026 | 45.46M |
| September 08, 2026 | 47.09M |
| September 04, 2026 | 47.57M |
| September 03, 2026 | 47.57M |
| September 02, 2026 | 49.69M |
| September 01, 2026 | 46.81M |
| August 31, 2026 | 47.00M |
| August 28, 2026 | 46.66M |
| August 27, 2026 | 46.96M |
| August 26, 2026 | 48.19M |
| August 25, 2026 | 47.90M |
| August 24, 2026 | 48.84M |
| August 21, 2026 | 48.82M |
| August 20, 2026 | 45.12M |
| August 19, 2026 | 47.94M |
| August 18, 2026 | 48.19M |
| August 17, 2026 | 49.28M |
| August 14, 2026 | 50.70M |
| August 13, 2026 | 48.34M |
| August 12, 2026 | 48.82M |
| August 11, 2026 | 48.19M |
| Date | Value |
|---|---|
| August 10, 2026 | 48.32M |
| August 07, 2026 | 48.19M |
| August 06, 2026 | 50.62M |
| August 05, 2026 | 49.75M |
| August 04, 2026 | 49.29M |
| August 03, 2026 | 48.70M |
| July 31, 2026 | 48.25M |
| July 30, 2026 | 47.57M |
| July 29, 2026 | 47.82M |
| July 28, 2026 | 48.82M |
| July 27, 2026 | 48.19M |
| July 24, 2026 | 48.19M |
| July 23, 2026 | 48.28M |
| July 22, 2026 | 49.57M |
| July 21, 2026 | 50.31M |
| July 20, 2026 | 49.46M |
| July 17, 2026 | 48.19M |
| July 16, 2026 | 48.78M |
| July 15, 2026 | 50.01M |
| July 14, 2026 | 49.99M |
| July 13, 2026 | 49.45M |
| July 10, 2026 | 49.53M |
| July 09, 2026 | 48.95M |
| July 08, 2026 | 50.08M |
| July 07, 2026 | 51.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 204.21B |
| AngioDynamics, Inc. | 610.95M |
| Alphatec Holdings, Inc. | 2.137B |
| AtriCure, Inc. | 2.766B |
| Baxter International, Inc. | 18.94B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.417M |
| Revenue (Quarterly) | 9.633M |
| Total Expenses (Quarterly) | 14.05M |
| EPS Diluted (Quarterly) | -1.407 |
| Gross Profit Margin (Quarterly) | 73.18% |
| Profit Margin (Quarterly) | -45.85% |
| Earnings Yield | -100.0% |
| Normalized Earnings Yield | -93.40 |